Identifying druggable targets for differentiation therapy in glioblastoma

Vedi l’offerta su Go Lavoro: golavoro.it/annuncio-lavoro/8jwn3s

Organisation/Company Università di Trento Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 9 Nov 2026 - 12:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Offer Description Glioblastoma (GBM) is the most common and aggressive central nervous system malignancy in adults. This research project aims to identify novel druggable molecular targets to advance differentiation therapy strategies for glioblastoma (GBM).



By inducing terminal differentiation of glioma stem cells (GSCs) and converting stem-like cells into non-stem states sensitive to conventional treatments, this project aims to reduce tumor intrinsic dynamic plasticity and achieve effective GBM eradication. (...)
AFRICA
EUROPE
OCEANIA
NORTH AMERICA
SOUTH AMERICA
ASIA
OTHER
E.U.
CHINA (MAINLAND)
CHINA (HONG KONG)
Eligibility of fellows: country/ies of residence:
AFRICA
EUROPE
OCEANIA
NORTH AMERICA
SOUTH AMERICA
ASIA
OTHER
E.U.
CHINA (MAINLAND)
CHINA (HONG KONG)
#J-18808-Ljbffr

Vedi l’offerta su Go Lavoro: golavoro.it/annuncio-lavoro/8jwn3s